← Scroll for more →
Akebia Therapeutics, Inc. (AKBA)
Pharmaceutical Preparations
Latest Price
$0.71
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.09
P/B Ratio
7.57
Institutional Ownership
38.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 19.99M | $22.0M | 7.35% | +1.29M | 2026-06-30 |
| Vanguard Capital Management LLC | 11.32M | $12.0M | 4.17% | +155.4K | 2026-06-30 |
| AQR Capital Management LLC | 9.15M | $10.0M | 3.37% | +7.36M | 2026-06-30 |
| Geode Capital Management, LLC | 6.73M | $7.0M | 2.48% | +275.1K | 2026-06-30 |
| State Street Corp | 5.39M | $6.0M | 1.98% | -6.22M | 2026-06-30 |
| Jacobs Levy Equity Management, Inc | 4.27M | $4.0M | 1.57% | +3.84M | 2026-06-30 |
| Goldman Sachs Group Inc | 3.69M | $4.0M | 1.36% | +86.3K | 2026-06-30 |
| Millennium Management LLC | 3.20M | $3.0M | 1.18% | +811.9K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2.53M | $2.0M | 0.93% | +318.5K | 2026-06-30 |
| Two Sigma Investments, LP | 2.44M | $2.0M | 0.90% | -- | 2026-06-30 |